🇺🇸 NBIX — Neurocrine Biosciences, Inc.

Salud Compra fuerte
← Volver

Precio actual

159,76 USD

Máx. histórico

185,50

98 días

Caída desde máximo

-13,88%

Rango 52 semanas

122,14 – 186,12

Variación hoy

-3,79%

Cierre anterior

166,05

Rango de hoy

159,53 – 167,68

Volumen hoy

1.482.485

Peor caída histórica

-97,21%

15/03/2006 → 12/11/2009

Recuperado en 2911 días

Volatilidad anualizada ⓘ

61,30%

Información
Nombre completo
Neurocrine Biosciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
2.500
PER ⓘ
23,70 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
207,50 USD (puede no estar actualizado)
Primera cotización
23/05/1996
Precio actualizado
hace 21 horas
Sobre la empresa

Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; Orilissa tablets for endometriosis; Oriahnn capsules to treat uterine fibroids; and CRENESSITY to treat congenital adrenal hyperplasia, as well as offers products under the name of ALKINDI and Efmody. Its product candidates in clinical development includes NBI-1076986 to treat movement disorders; Osavampator for inadequate response to treatment in major depressive disorder; NBI-1117568 for the treatment of schizophrenia and bipolar mania; NBI-1117567 for the treatment of Alzheimer's disease; NBI 921355 for the treatment of epilepsy; NBIP-01435 for the treatment of congenital adrenal hyperplasia; NBIP-2118 for the treatment of obesity and related metabolic diseases; and NBI-1070770 to treat major depressive disorder; and NBI-1117570, NBI-1117567, NBI-1117569, NBI-1140675, and NBI-1065890 for neuropsychiatric and neurological conditions. The company also has license and collaboration agreements with Nxera Pharma UK Limited; Takeda Pharmaceutical Company Limited; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; Sanofi S.A.; Tanabe Pharma Corporation; and AbbVie Inc. The company was incorporated in 1992 and is headquartered in San Diego, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
26/04/2001 22,99 24,87 21,85 23,93 +3,95% 13,14% 147.000
25/04/2001 21,78 23,75 20,10 23,02 +6,08% 16,76% 92.100
24/04/2001 20,86 22,25 20,70 21,70 +1,45% 7,43% 124.300
23/04/2001 22,51 22,51 21,00 21,39 -5,14% 6,71% 72.000
20/04/2001 23,25 23,61 22,52 22,55 -4,49% 4,69% 301.300
19/04/2001 24,50 24,50 22,77 23,61 -2,96% 7,06% 320.400
18/04/2001 23,16 25,00 23,05 24,33 +4,33% 8,42% 253.400
17/04/2001 22,57 23,32 21,75 23,32 +6,68% 6,96% 30.900
16/04/2001 21,70 22,32 21,03 21,86 -2,41% 5,94% 61.300
12/04/2001 21,00 22,60 20,36 22,40 +7,28% 10,67% 84.900
11/04/2001 22,25 22,70 20,80 20,88 -3,02% 8,54% 184.800
10/04/2001 20,00 21,89 20,00 21,53 +8,30% 9,45% 214.500
09/04/2001 18,99 20,45 18,74 19,88 +6,74% 9,00% 135.200
06/04/2001 20,13 20,56 18,00 18,63 -9,15% 12,73% 127.100
05/04/2001 18,38 20,88 18,31 20,50 +12,33% 13,95% 173.700
04/04/2001 17,88 18,88 17,81 18,25 +2,82% 5,94% 226.100
03/04/2001 19,50 19,50 16,75 17,75 -10,13% 14,10% 197.600
02/04/2001 20,56 20,56 19,63 19,75 -4,24% 4,56% 247.200
30/03/2001 19,30 20,63 19,13 20,63 +6,45% 7,77% 100.000
29/03/2001 19,44 19,88 19,09 19,38 -0,64% 4,02% 139.100
28/03/2001 19,19 19,63 19,06 19,50 -0,95% 2,93% 81.400
27/03/2001 18,44 20,13 17,50 19,69 +5,70% 14,24% 200.700
26/03/2001 17,50 19,00 17,38 18,63 +6,81% 9,29% 153.600
23/03/2001 16,13 18,56 15,94 17,44 +10,28% 16,28% 217.400
22/03/2001 15,56 15,94 14,25 15,81 +0,40% 10,84% 312.200
21/03/2001 15,56 15,94 14,94 15,75 -1,18% 6,43% 583.500
20/03/2001 17,19 17,25 15,75 15,94 -8,27% 8,73% 318.100
19/03/2001 15,75 17,38 15,75 17,38 +8,59% 10,32% 233.900
16/03/2001 16,56 16,94 15,25 16,00 -2,66% 10,19% 167.400
15/03/2001 15,88 17,00 15,88 16,44 +5,20% 7,09% 302.700